Skip to content

INIFY Laboratories AB Sustainability Reports

INIFY Laboratories AB provides digital, AI-supported, and standardized histopathology laboratory services, specializing in clinical cancer diagnostics for prostate cancer and gastroenterology.

Sector: Healthcare & social services

Country: Sweden

Exchange: Oslo Børs

LEI: 549300306YYJ3BX3VB98

FIGI: BBG0156H7B01

4 reports from 2022 to 2025